Mycoplasma genitalium infection in the female reproductive system: Diseases and treatment

is a newly emerged sexually transmitted disease pathogen and an independent risk factor for female cervicitis and pelvic inflammatory disease. The clinical symptoms caused by infection are mild and easily ignored. If left untreated, can grow along the reproductive tract and cause salpingitis, leadin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in microbiology 2023-02, Vol.14, p.1098276-1098276
Hauptverfasser: Yu, Jianwei, Zhou, Yan, Luo, Haodang, Su, Xiaoling, Gan, Tian, Wang, Jingyun, Ye, Zufeng, Deng, Zhongliang, He, Jun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:is a newly emerged sexually transmitted disease pathogen and an independent risk factor for female cervicitis and pelvic inflammatory disease. The clinical symptoms caused by infection are mild and easily ignored. If left untreated, can grow along the reproductive tract and cause salpingitis, leading to infertility and ectopic pregnancy. Additionally, infection in late pregnancy can increase the incidence of preterm birth. infections are often accompanied by co-infection with other sexually transmitted pathogens ( , , and ) and viral infections (Human Papilloma Virus and Human Immunodeficiency Virus). A recent study suggested that plays a role in tumor development in the female reproductive system. However, few studies endorsed this finding. In recent years, has evolved into a new "superbug" due to the emergence of macrolide-and fluoroquinolone-resistant strains leading to frequent therapy failures. This review summarizes the pathogenic characteristics of and the female reproductive diseases caused by (cervicitis, pelvic inflammatory disease, ectopic pregnancy, infertility, premature birth, co-infection, reproductive tumors, etc.), as well as its potential relationship with reproductive tumors and clinical treatment.
ISSN:1664-302X
1664-302X
DOI:10.3389/fmicb.2023.1098276